Neoadjuvant treatment strategies for hepatocellular carcinoma
Lei Xu, Lin Chen, Wei Zhang
Abstract
The incidence of hepatocellular carcinoma (HCC) remains high globally. Surgical treatment is the best treatment for improving the prognosis of patients with HCC. Neoadjuvant therapy plays a key role in preventing tumor progression and even downstaging HCC. The liver transplantation rate and resectability rate have increased for neoadjuvant therapy. Neoadjuvant therapy is effective in different stages of HCC. In this review, we summarized the definition, methods, effects, indications and contraindications of neoadjuvant therapy in HCC, which have significance for guiding treatment.
Topics & Concepts
MedicineHepatocellular carcinomaNeoadjuvant therapyLiver transplantationSurgeryIncidence (geometry)OncologyInternal medicineTransplantationCancerBreast cancerPhysicsOpticsHepatocellular Carcinoma Treatment and PrognosisCholangiocarcinoma and Gallbladder Cancer StudiesCancer Mechanisms and Therapy